INTERNATIONAL PATENT: EYEBIOKOREA, INC., 주식회사 아이바이오코리아 FILES APPLICATION FOR "NOVEL PEPTIDE HAVING THERAPEUTIC EFFECT ON INFLAMMATORY DISEASES AND USE THEREOF"

GENEVA, Dec. 10 -- EYEBIOKOREA, INC. (2F, 81 Jinsa-ro 83beon-gil,Busanjin-guBusan 47397), 주식회사 아이바이오코리아 (부산광역시부산진구진사로83번길 81, 2층) filed a patent application (PCT/KR2025/004838) for "NOVEL PEPTIDE HAVING THERAPEUTIC EFFECT ON INFLAMMATORY DISEASES, AND USE THEREOF" on Apr 09, 2025. With publication no. WO/2025/249754, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organi...